Clinical Trial Update: Axillary Reverse Mapping [Phase 2]

View source ↗

Summary

Update on a Phase 2 clinical trial of axillary reverse mapping for breast cancer, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Arkansas | Conditions: Cancer of the Breast | Phase 2 | Status: ACTIVE_NOT_RECRUITING